Article Information
History
- November 22, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jocelyn Moyes1,2,*,
- Stefano Tempia1,3,
- Sibongile Walaza1,2,
- Meredith L. McMorrow4,5,
- Adam L. Cohen4,6,
- Florette Treurnicht1,
- Orienka Hellferscee1,
- Nicole Wolter1,7,
- Anne Von Gottberg1,7,
- Halima Dawood8,9,
- Ebrahim Variava10,11,
- Kathleen Kahn12,
- Shabir A. Madhi13,14 and
- Cheryl Cohen1,2,†
- 1Center for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
- 2School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 3MassGenics, Atlanta, Georgia, United States of America and Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa
- 4Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America and Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa
- 5Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
- 6Global Immunization Monitoring and Surveillance, Expanded Programme on Immunization
- Department of Immunization, Vaccines and Biologicals World Health Organization
- 7School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 8Department of Medicine, Greys Hospital, Pietermaritzburg, South Africa
- 9Caprisa, University of KwaZulu Natal, Pietermaritzburg, South Africa
- 10Department of Medicine, Klerksdorp-Tshepong Hospital Complex, Klerksdorp, South Africa
- 11Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 12MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg. Epidemiology and Global Health Unit
- 13South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of the Witwatersrand, Johannesburg, South Africa
- 14African Leadership in Vaccinology Expertise, University of the Witwatersrand, Johannesburg, South Africa
- ↵*Corresponding author:
Jocelyn Moyes, Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, PVT Bag X4, Sandringham, 2131, Gauteng, South Africa. Email jossmoyes{at}gmail.com - ↵†Alternate corresponding author:
Cheryl Cohen, Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Private Bag X4, Sandringham, 2131, Gauteng, South Africa. E-mail: cherylc{at}nicd.ac.za
Posted November 22, 2022.
The attributable fraction of respiratory syncytial virus among patients of different age with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016
